Loading...
Metabolic imaging using hyperpolarized (13)C‐pyruvate to assess sensitivity to the B‐Raf inhibitor vemurafenib in melanoma cells and xenografts
Nearly all melanoma patients with a BRAF‐activating mutation will develop resistance after an initial clinical benefit from BRAF inhibition (BRAFi). The aim of this work is to evaluate whether metabolic imaging using hyperpolarized (HP) (13)C pyruvate can serve as a metabolic marker of early respons...
Na minha lista:
| Udgivet i: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6991684/ https://ncbi.nlm.nih.gov/pubmed/31833658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14890 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|